0001562180-22-004813.txt : 20220603
0001562180-22-004813.hdr.sgml : 20220603
20220603174611
ACCESSION NUMBER: 0001562180-22-004813
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220601
FILED AS OF DATE: 20220603
DATE AS OF CHANGE: 20220603
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Nelli James Patrick Jr.
CENTRAL INDEX KEY: 0001780883
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38993
FILM NUMBER: 22995984
MAIL ADDRESS:
STREET 1: C/O HEALTH CATALYST, INC.
STREET 2: 3165 E.MILLROCK DRIVE #400
CITY: SALT LAKE CITY
STATE: UT
ZIP: 84121
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Health Catalyst, Inc.
CENTRAL INDEX KEY: 0001636422
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMPUTER PROGRAMMING, DATA PROCESSING, ETC. [7370]
IRS NUMBER: 453337483
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 10897 SOUTH RIVER FRONT PARKWAY, #300
CITY: SOUTH JORDAN
STATE: UT
ZIP: 84095
BUSINESS PHONE: 801-708-6800
MAIL ADDRESS:
STREET 1: 10897 SOUTH RIVER FRONT PARKWAY, #300
CITY: SOUTH JORDAN
STATE: UT
ZIP: 84095
FORMER COMPANY:
FORMER CONFORMED NAME: HQC Holdings, Inc.
DATE OF NAME CHANGE: 20150312
4
1
primarydocument.xml
PRIMARY DOCUMENT
X0306
4
2022-06-01
false
0001636422
Health Catalyst, Inc.
HCAT
0001780883
Nelli James Patrick Jr.
C/O HEALTH CATALYST, INC.
10897 SOUTH RIVER FRONT PARKWAY, #300
SOUTH JORDAN
UT
84095
false
true
false
false
President
Common Stock
2022-06-01
4
F
false
3241.00
14.2371
D
268502.00
D
Common Stock
2022-06-01
4
F
false
118.00
14.9522
D
268384.00
D
Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Issuer's Restricted Stock Units. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person.
Represents the weighted average sale price of the shares sold ranging from $13.91 to $14.90 per share, inclusive.
Represents the weighted average sale price of the shares sold ranging from $14.91 to $15.07 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in Footnotes (2) and (3).
/s/ Daniel Orenstein, as Attorney-in-Fact
2022-06-03